Global Intravenous Solution Market, By Solution (Saline (Normal Saline (0.9% NaCl) and Hypertonic Saline), Dextran, Lactated Ringer’s, Amino Acid, Vitamins & Minerals, Heparin and Trace Elements, and Mixed Solutions), By Bag Type (Large Volume Bags (greater than 250ml) and Small Volume Bags (less than 250ml)), By Application (Basic IV Solution, Nutritional IV Solution, Blood IV Solution, Drug IV Solution, and Irrigation IV Solution), By End-user (Hospitals, Clinics, Ambulatory Surgery Centers, and Home Care Settings), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 8,372.0 million in 2019, and is expected to exhibit a CAGR of 6.1% over the forecast period (2019 - 2027), as highlighted in a new report published by.

Increasing cases of kidney failures are expected to lead to high adoption of dialysis procedures, which is expected to drive the market growth over the forecast period. Kidney failure is a condition in which the kidney loses its functioning ability of removing waste and extra fluids from the body. Dialysis procedure is recommended for such conditions. For instance, according to the National Kidney Foundation Factsheet, in March 2015, an estimated 10% of the global population was affected by chronic kidney disease (CKD), and around 2 million people received treatment for kidney failure. Moreover, according to the National Institute of Health (NIH), in December 2016, an estimated 661,000 people in the U.S. suffered from kidney failure. Among these, around 468,000 patients were on dialysis, and around 193,000 underwent kidney transplant procedures. According to the same source, around 88.2% of end-stage renal disease (ESRD) patients in the U.S. underwent renal replacement therapy with hemodialysis. 9.0% of these patients received peritoneal dialysis, and 2.6% had received kidney transplant in 2013.

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/1134

Browse 34 Market Data Tables and 35 Figures spread through 215 Pages and in-depth TOC on "Intravenous Solution Market, By Solution (Saline (Normal Saline (0.9% NaCl) and Hypertonic Saline), Dextran, Lactated Ringer’s, Amino Acid, Vitamins & Minerals, Heparin and Trace Elements, and Mixed Solutions), By Bag Type (Large Volume Bags (greater than 250ml) and Small Volume Bags (less than 250ml)), By Application (Basic IV Solution, Nutritional IV Solution, Blood IV Solution, Drug IV Solution, and Irrigation IV Solution), By End-user (Hospitals, Clinics, Ambulatory Surgery Centers and, Home Care Settings), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Global Forecast to 2027"

Major market players are focused on development of products, which enhances patient safety and prevents IV medication administration errors in order to avoid patient injury and lowering pain. For instance, in March 2017, Becton, Dickinson and Company launched an IV Medication Safety Solution, at the European Association of Hospital Pharmacists (EAHP) congress, in France. This product was developed for prevention of IV medication administration errors.

Browse Research Report: https://www.coherentmarketinsights.com/market-insight/intravenous-solutions-market-1134

Key Takeaways of the Intravenous Solution Market:

The global intravenous solution market is expected to expand at a CAGR of 6.1% over the forecast period (2019–2027), owing to increasing cases of kidney failure and dialysis

Among solution type, the saline solution segment is expected to account for major revenue share in 2027, owing to increasing incidence of gastroenteritis globally. For instance, according to the Global Burden of Disease Study, in 2015, there were two billion cases of gastroenteritis, resulting in 1.3 million deaths globally.

Major players operating in the global intravenous solution market include Baxter International Inc, ICU Medical, Inc, B. Braun Melsungen Ag, Grifols, S.A., Fresenius Kabi USA, LLC, Vifor Pharma Management Ltd, JW Life Science, Amanta Healthcare, Axa Parenterals Ltd, and Salius Pharma Private Limited

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/1134

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
mailto:[email protected]
U.S. Office:
Name: Mr. Shah
Coherent Market Insights 1001 4th Ave,
# 3200 Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737